| scholarly article | Q13442814 |
| P50 | author | Robert H Mach | Q88117640 |
| P2093 | author name string | Dong Zhou | |
| Michael J Welch | |||
| Delphine L Chen | |||
| Hsiaoju Lee | |||
| Justin M Rothfuss | |||
| Datta E Ponde | |||
| P2860 | cites work | 2-Amino-4-methylpyridine as a potent inhibitor of inducible NO synthase activity in vitro and in vivo | Q24755844 |
| Nitric oxide synthases: structure, function and inhibition | Q28207668 | ||
| Nitric oxide as a secretory product of mammalian cells | Q29620372 | ||
| Mammalian nitric oxide synthases | Q33631306 | ||
| Nitric oxide in septic shock | Q33631375 | ||
| Inhibition of nitric oxide synthase as a potential therapeutic target | Q33636670 | ||
| Pharmacological modulation of nitric oxide synthesis by mechanism-based inactivators and related inhibitors | Q33793673 | ||
| Nitric oxide in the pathogenesis of vascular disease | Q33843539 | ||
| Blocking NO synthesis: how, where and why? | Q35013972 | ||
| The role of nitric oxide in cancer | Q35045661 | ||
| Regulatory effects of iNOS on acute lung inflammatory responses in mice | Q35843243 | ||
| Inducible nitric oxide synthase (iNOS) in tumor biology: the two sides of the same coin | Q36137784 | ||
| Modulation of prostaglandin biosynthesis by nitric oxide and nitric oxide donors | Q36138113 | ||
| Molecular pathophysiology of Parkinson's disease | Q36196507 | ||
| Synthesis and evaluation of a fluorine-18 labeled antisense oligonucleotide as a potential PET tracer for iNOS mRNA expression | Q38339628 | ||
| BYK191023 (2-[2-(4-methoxy-pyridin-2-yl)-ethyl]-3h-imidazo[4,5-b]pyridine) is an NADPH- and time-dependent irreversible inhibitor of inducible nitric-oxide synthase | Q40027935 | ||
| The novel imidazopyridine 2-[2-(4-methoxy-pyridin-2-yl)-ethyl]-3H-imidazo[4,5-b]pyridine (BYK191023) is a highly selective inhibitor of the inducible nitric-oxide synthase | Q40362241 | ||
| Molecular mechanisms and therapeutic strategies related to nitric oxide. | Q40413002 | ||
| GW274150 and GW273629 are potent and highly selective inhibitors of inducible nitric oxide synthase in vitro and in vivo | Q40444904 | ||
| Nitric oxide synthase structure and mechanism | Q40487439 | ||
| Synthesis and evaluation of two positron-labeled nitric oxide synthase inhibitors, S-[11C]methylisothiourea and S-(2-[18F]fluoroethyl)isothiourea, as potential positron emission tomography tracers | Q41144499 | ||
| Identification of N-iminoethyl-l-ornithine as an irreversible inhibitor of nitric oxide synthase in phagocytic cells | Q41706646 | ||
| Isothioureas: potent inhibitors of nitric oxide synthases with variable isoform selectivity | Q42068720 | ||
| L-N6-(1-iminoethyl)lysine: a selective inhibitor of inducible nitric oxide synthase. | Q42275426 | ||
| 1400W is a slow, tight binding, and highly selective inhibitor of inducible nitric-oxide synthase in vitro and in vivo | Q42551195 | ||
| 3,4-Dihydro-1-isoquinolinamines: a novel class of nitric oxide synthase inhibitors with a range of isoform selectivity and potency | Q43591287 | ||
| 2-aminopyridines as highly selective inducible nitric oxide synthase inhibitors. Differential binding modes dependent on nitrogen substitution. | Q44910629 | ||
| Effects of NG-nitro-L-arginine and L-arginine on regional cerebral blood flow in the cat | Q45177787 | ||
| Importance of basal nitric oxide synthesis in regulation of myocardial blood flow. | Q54291105 | ||
| Differential regulation of the constitutive and inducible nitric oxide synthase mRNA by lipopolysacchride treatment in vivo in the rat | Q61712889 | ||
| Control of regional blood flow by endothelium-derived nitric oxide | Q68767825 | ||
| 2-Iminopiperidine and other 2-iminoazaheterocycles as potent inhibitors of human nitric oxide synthase isoforms | Q70939319 | ||
| Potent and selective inhibition of human nitric oxide synthases. Selective inhibition of neuronal nitric oxide synthase by S-methyl-L-thiocitrulline and S-ethyl-L-thiocitrulline | Q71650800 | ||
| Immunochemical localization of inducible nitric oxide synthase in endotoxin-treated rats | Q71657787 | ||
| S-alkyl-L-thiocitrullines. Potent stereoselective inhibitors of nitric oxide synthase with strong pressor activity in vivo | Q71692350 | ||
| Inhibition of inducible nitric oxide synthase by acetamidine derivatives of hetero-substituted lysine and homolysine | Q73604406 | ||
| A potent inhibitor of inducible nitric oxide synthase, ONO-1714, a cyclic amidine derivative | Q73642569 | ||
| Analgesic activity of 2-amino-4-methylpyridine, a novel NO synthase inhibitor | Q73698455 | ||
| Substituted 2-aminopyridines as inhibitors of nitric oxide synthases | Q74315108 | ||
| Lung, spleen, and kidney are the major places for inducible nitric oxide synthase expression in endotoxic shock: role of p38 mitogen-activated protein kinase in signal transduction of inducible nitric oxide synthase expression | Q75447445 | ||
| Catalysis by nitric oxide synthase | Q77565785 | ||
| P433 | issue | 8 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | drug discovery | Q1418791 |
| P304 | page(s) | 2443-53 | |
| P577 | publication date | 2009-04-23 | |
| P1433 | published in | Journal of Medicinal Chemistry | Q900316 |
| P1476 | title | Design and synthesis of 2-amino-4-methylpyridine analogues as inhibitors for inducible nitric oxide synthase and in vivo evaluation of [18F]6-(2-fluoropropyl)-4-methyl-pyridin-2-amine as a potential PET tracer for inducible nitric oxide synthase | |
| P478 | volume | 52 |
| Q36801243 | Antisense peptide nucleic acid-functionalized cationic nanocomplex for in vivo mRNA detection |
| Q37388254 | Design, Synthesis, and In Vitro and In Vivo Evaluation of an (18)F-Labeled Sphingosine 1-Phosphate Receptor 1 (S1P1) PET Tracer. |
| Q35876564 | Dual peptide nucleic acid- and peptide-functionalized shell cross-linked nanoparticles designed to target mRNA toward the diagnosis and treatment of acute lung injury |
| Q48125619 | Effects of nitric oxide synthase inhibition in the dorsolateral periaqueductal gray matter on ethanol withdrawal-induced anxiety-like behavior in rats |
| Q38670162 | Fluorine-18 patents (2009-2015). Part 1: novel radiotracers |
| Q36920403 | Imaging caspase-3 activation as a marker of apoptosis-targeted treatment response in cancer |
| Q35849789 | Imaging pulmonary inducible nitric oxide synthase expression with PET. |
| Q58886603 | Microwave Irradiation–Assisted Amination of 2-Chloropyridine Derivatives with Amide Solvents |
| Q89529378 | Molecular Imaging of Pulmonary Inflammation and Infection |
| Q33624653 | Molecular Targets for PET Imaging of Activated Microglia: The Current Situation and Future Expectations |
| Q78436121 | Nocapyrones H–J, 3,6-Disubstituted α-Pyrones from the Marine Actinomycete Nocardiopsis sp. KMF-001 |
| Q38884546 | Re(I) and Tc(I) complexes for targeting nitric oxide synthase: influence of the chelator in the affinity for the enzyme. |
| Q38156683 | Recent advances in metabolic imaging |
Search more.